The House passed its version of a “right-to-try” bill on Wednesday, but it gained little notice because it was overshadowed by the omnibus spending bill that had just become public and which President Trump signed on Friday.

The right-to-try legislation, if signed into law, will allow terminally ill patients to seek drug treatments that have passed phase one of the FDA’s approval process, but have not yet received full approval.

Recommended Stories

Daily on Healthcare: Shareholders green light CVS-Aetna deal

FDA moved at warp speed on COVID-19 vaccine, but the precedent may not stick

Trump keeps his promise, dying patients get a second chance at life